70 related articles for article (PubMed ID: 15820916)
1. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.
Dohi T; Beltrami E; Wall NR; Plescia J; Altieri DC
J Clin Invest; 2004 Oct; 114(8):1117-27. PubMed ID: 15489959
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
Cui Q; Huang C; Liu JY; Zhang JT
J Med Chem; 2023 Dec; 66(24):16515-16545. PubMed ID: 38092421
[TBL] [Abstract][Full Text] [Related]
3. Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment.
Berthenet K; Aïmontché E; El Mrini S; Brière J; Pion N; Iacono I; Brejon S; Monier K; Catez F; Ichim G; Combaret V; Mertani HC; Diaz JJ; Albaret MA
Sci Rep; 2024 Feb; 14(1):3768. PubMed ID: 38355966
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.
Mallolas J; Rodríguez R; Gubern C; Camós S; Serena J; Castellanos M
Neuromolecular Med; 2014 Dec; 16(4):856-61. PubMed ID: 25344020
[TBL] [Abstract][Full Text] [Related]
5. Function of alternative splicing.
Kelemen O; Convertini P; Zhang Z; Wen Y; Shen M; Falaleeva M; Stamm S
Gene; 2013 Feb; 514(1):1-30. PubMed ID: 22909801
[TBL] [Abstract][Full Text] [Related]
6. Relationship of survivin to clinical drug resistance in Burkitt's lymphoma of the head and neck region.
Zyada MM
Med Oncol; 2011 Dec; 28(4):1565-9. PubMed ID: 20524087
[TBL] [Abstract][Full Text] [Related]
7. Role of survivin and its splice variants in tumorigenesis.
Li F
Br J Cancer; 2005 Jan; 92(2):212-6. PubMed ID: 15611788
[TBL] [Abstract][Full Text] [Related]
8. Alternative splice variants of survivin as potential targets in cancer.
Sampath J; Pelus LM
Curr Drug Discov Technol; 2007 Oct; 4(3):174-91. PubMed ID: 17986000
[TBL] [Abstract][Full Text] [Related]
9. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
[TBL] [Abstract][Full Text] [Related]
10. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy.
Végran F; Boidot R; Oudin C; Riedinger JM; Bonnetain F; Lizard-Nacol S
Clin Cancer Res; 2006 Oct; 12(19):5794-800. PubMed ID: 17020986
[TBL] [Abstract][Full Text] [Related]
13. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.
Malcles MH; Wang HW; Koumi A; Tsai YH; Yu M; Godfrey A; Boshoff C
Br J Cancer; 2007 Jun; 96(11):1659-66. PubMed ID: 17505517
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
